Trial Profile
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study and Open-Label Study to Evaluate the Efficacy and Safety of Abatacept in Combination Therapy With Methotrexate Versus Methotrexate Alone in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Acronyms AIM
- Sponsors Bristol-Myers Squibb
- 11 Jun 2016 Results a post hoc analysis from AIM and ATTAIN and AGREE (n=1536) presented at the 17th Annual Congress of the European League Against Rheumatism
- 01 May 2014 5-years results were published in The Journal of Rheumatology.
- 28 May 2011 Results presented at the 12th Annual Congress of the European League Against Rheumatism.